GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.4000
-0.0143 (-3.45%)
Mar 31, 2026, 9:39 AM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $12.62 million as of March 31, 2026. Its market cap has increased by 121.43% in one year.
Market Cap
12.62M
Enterprise Value
6.26M
1-Year Change
121.43%
Ranking
Category
Stock Price
$0.40
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $12.62M, a decrease of -84.83%. That is a compound annual growth rate of -20.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 13.10M | 57.83% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IO Biotech | 13.89M |
| IN8bio | 13.88M |
| FibroBiologics | 13.29M |
| Moleculin Biotech | 13.02M |
| BioAtla | 12.69M |
| BioCardia | 12.69M |
| Lantern Pharma | 12.53M |
| Hoth Therapeutics | 12.50M |